Yun Zeng

Title: Innovations of Yun Zeng in Peptide Nucleic Acids

Introduction

Yun Zeng is a notable inventor based in Singapore, recognized for his contributions to the field of peptide nucleic acids. His innovative work has led to the development of a unique peptide nucleic acid monomer, which has significant implications in biotechnology and molecular biology.

Latest Patents

Yun Zeng holds a patent for peptide nucleic acid monomers and oligomers. The patent discloses a peptide nucleic acid monomer that comprises a terminal amino group and a terminal group A. These components are connected by an aliphatic moiety, which is free of groups that are charged under physiological conditions. The terminal group A can be one of several functional groups, including —COOH, —COOR, —COX, —COSR, —CN, —CONH, —CONHR, —CONR, where R and R4 can be hydrogen or various aliphatic, alicyclic, aromatic, arylaliphatic, or arylalicyclic groups. The terminal amino group is further substituted by an aliphatic group with a main chain of at least two carbon atoms, optionally containing heteroatoms such as N, O, S, Se, and Si.

Career Highlights

Yun Zeng is affiliated with Nanyang Technological University, where he continues to advance research in the field of peptide nucleic acids. His work is characterized by a strong focus on the synthesis and application of novel nucleic acid structures.

Collaborations

Yun Zeng has collaborated with esteemed colleagues, including Chuan Fa Liu and Xiao Wei Lu, to further enhance the research and development of peptide nucleic acids.

Conclusion

Yun Zeng's innovative contributions to peptide nucleic acids exemplify the potential of his research in advancing biotechnology. His patent and ongoing work at Nanyang Technological University highlight his role as a significant figure in this scientific domain.